Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatmentJamie J Beagan, Sander Bach, Robert A van Boerdonk, et al.
International Journal of Cancer|April 13, 2011
Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening programMurat Gök, Folkert J van Kemenade, Daniëlle A M Heideman, et al.
The Lancet. Oncology|December 20, 2011
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialDorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, et al.
International Journal of Cancer|November 1, 2011
Human papillomavirus infection in women with and without cervical cancer in Tehran, IranNahid Khodakarami, Gary M Clifford, Parvin Yavari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testingI H Nauta, M M Rietbergen, A A J D van Bokhoven, et al.
The Journal of Infectious Diseases|May 18, 2018
Detection of Incident Anal High-Risk Human Papillomavirus DNA in Men Who Have Sex With Men: Incidence or Reactivation?Denise E Twisk, Marianne A B van der Sande, Arne van Eeden, et al.
Frontiers in Immunology|February 22, 2017
<i>In Vivo</i> Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal CancerJohn P Veluchamy, Silvia Lopez-Lastra, Jan Spanholtz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 31, 2020
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohortF J Vink, B I Lissenberg-Witte, C J L M Meijer, et al.
Clinical Epigenetics|June 23, 2018
Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility studyIris Babion, Barbara C Snoek, Putri W Novianti, et al.
International Journal of Cancer|June 29, 2026
Triage Performance of FAM19A4/miR124-2 Methylation: 18-Month Follow-Up Results From a Prospective Observational Study Within the Dutch Primary HPV-Based Cervical Screening ProgramLisanne Verhoef, Mila S Griffioen, Maaike C G Bleeker, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatmentJamie J Beagan, Sander Bach, Robert A van Boerdonk, et al.
International Journal of Cancer|April 13, 2011
Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening programMurat Gök, Folkert J van Kemenade, Daniëlle A M Heideman, et al.
The Lancet. Oncology|December 20, 2011
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialDorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, et al.
International Journal of Cancer|November 1, 2011
Human papillomavirus infection in women with and without cervical cancer in Tehran, IranNahid Khodakarami, Gary M Clifford, Parvin Yavari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testingI H Nauta, M M Rietbergen, A A J D van Bokhoven, et al.
The Journal of Infectious Diseases|May 18, 2018
Detection of Incident Anal High-Risk Human Papillomavirus DNA in Men Who Have Sex With Men: Incidence or Reactivation?Denise E Twisk, Marianne A B van der Sande, Arne van Eeden, et al.
Frontiers in Immunology|February 22, 2017
<i>In Vivo</i> Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal CancerJohn P Veluchamy, Silvia Lopez-Lastra, Jan Spanholtz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 31, 2020
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohortF J Vink, B I Lissenberg-Witte, C J L M Meijer, et al.
Clinical Epigenetics|June 23, 2018
Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility studyIris Babion, Barbara C Snoek, Putri W Novianti, et al.
International Journal of Cancer|June 29, 2026
Triage Performance of FAM19A4/miR124-2 Methylation: 18-Month Follow-Up Results From a Prospective Observational Study Within the Dutch Primary HPV-Based Cervical Screening ProgramLisanne Verhoef, Mila S Griffioen, Maaike C G Bleeker, et al.
Pageof 28